ADIPOQ and colorectal carcinoma: Adiponectin also mitigates the phosphatidylinositol-3-kinase/AKT (PI3K/AKT) pathway to limit carcinogenesis, tumor cell adhesion, and migration within CRC, with lower levels showing the opposite effects (Figure 2B) [47].